Clinical potential of fasting in type 1 diabetes

Krista A. Varady; Mary Claire Runchey; Sirimon Reutrakul; Alaina P. Vidmar; Lisa S. Chow

doi:10.1016/j.tem.2024.01.007

Clinical potential of fasting in type 1 diabetes

Krista A. Varady, Mary Claire Runchey, Sirimon Reutrakul, Alaina P. Vidmar, Lisa S. Chow

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Most adults with type 1 diabetes (T1DM) are either overweight or obese. As such, dietary management is recommended as an adjunct to insulin treatment to improve glycemic control and facilitate weight loss in these patients. Time-restricted eating (TRE) is a form of intermittent fasting that offers a simplified approach to treating obesity in T1DM. TRE typically involves restricting eating to 6 to 10 h per day, with water and medications allowed outside the eating window. This review examines the efficacy of TRE and other fasting protocols in improving weight and glycemic control in patients with obesity and T1DM. This review will also evaluate the safety of these regimens and provide advice to clinicians on implementing intermittent fasting in T1DM.

Original language	English (US)
Pages (from-to)	413-424
Number of pages	12
Journal	Trends in Endocrinology and Metabolism
Volume	35
Issue number	5
DOIs	https://doi.org/10.1016/j.tem.2024.01.007
State	Published - May 2024

Bibliographical note

Publisher Copyright:
© 2024 Elsevier Ltd

Keywords

glycemic control
intermittent fasting
obesity
safety
time-restricted eating
type 1 diabetes

PubMed: MeSH publication types

Journal Article
Review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/j.tem.2024.01.007

Find It

Find It at U of M Libraries

Cite this

@article{64a2517ab64c4aec8bd6ba012529c639,

title = "Clinical potential of fasting in type 1 diabetes",

abstract = "Most adults with type 1 diabetes (T1DM) are either overweight or obese. As such, dietary management is recommended as an adjunct to insulin treatment to improve glycemic control and facilitate weight loss in these patients. Time-restricted eating (TRE) is a form of intermittent fasting that offers a simplified approach to treating obesity in T1DM. TRE typically involves restricting eating to 6 to 10 h per day, with water and medications allowed outside the eating window. This review examines the efficacy of TRE and other fasting protocols in improving weight and glycemic control in patients with obesity and T1DM. This review will also evaluate the safety of these regimens and provide advice to clinicians on implementing intermittent fasting in T1DM.",

keywords = "glycemic control, intermittent fasting, obesity, safety, time-restricted eating, type 1 diabetes",

author = "Varady, {Krista A.} and Runchey, {Mary Claire} and Sirimon Reutrakul and Vidmar, {Alaina P.} and Chow, {Lisa S.}",

note = "Publisher Copyright: {\textcopyright} 2024 Elsevier Ltd",

year = "2024",

month = may,

doi = "10.1016/j.tem.2024.01.007",

language = "English (US)",

volume = "35",

pages = "413--424",

journal = "Trends in Endocrinology and Metabolism",

issn = "1043-2760",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Clinical potential of fasting in type 1 diabetes

AU - Varady, Krista A.

AU - Runchey, Mary Claire

AU - Reutrakul, Sirimon

AU - Vidmar, Alaina P.

AU - Chow, Lisa S.

PY - 2024/5

Y1 - 2024/5

N2 - Most adults with type 1 diabetes (T1DM) are either overweight or obese. As such, dietary management is recommended as an adjunct to insulin treatment to improve glycemic control and facilitate weight loss in these patients. Time-restricted eating (TRE) is a form of intermittent fasting that offers a simplified approach to treating obesity in T1DM. TRE typically involves restricting eating to 6 to 10 h per day, with water and medications allowed outside the eating window. This review examines the efficacy of TRE and other fasting protocols in improving weight and glycemic control in patients with obesity and T1DM. This review will also evaluate the safety of these regimens and provide advice to clinicians on implementing intermittent fasting in T1DM.

AB - Most adults with type 1 diabetes (T1DM) are either overweight or obese. As such, dietary management is recommended as an adjunct to insulin treatment to improve glycemic control and facilitate weight loss in these patients. Time-restricted eating (TRE) is a form of intermittent fasting that offers a simplified approach to treating obesity in T1DM. TRE typically involves restricting eating to 6 to 10 h per day, with water and medications allowed outside the eating window. This review examines the efficacy of TRE and other fasting protocols in improving weight and glycemic control in patients with obesity and T1DM. This review will also evaluate the safety of these regimens and provide advice to clinicians on implementing intermittent fasting in T1DM.

KW - glycemic control

KW - intermittent fasting

KW - obesity

KW - safety

KW - time-restricted eating

KW - type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85184784762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85184784762&partnerID=8YFLogxK

U2 - 10.1016/j.tem.2024.01.007

DO - 10.1016/j.tem.2024.01.007

M3 - Review article

C2 - 38331668

AN - SCOPUS:85184784762

SN - 1043-2760

VL - 35

SP - 413

EP - 424

JO - Trends in Endocrinology and Metabolism

JF - Trends in Endocrinology and Metabolism

IS - 5

ER -

Clinical potential of fasting in type 1 diabetes

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this